Astrana Health Inc. logo

Astrana Health Inc.

ASTH | NASDAQ
Chart Builder DCF Calculator
$33.55
-$0.81 (-2.36%)
At close: Sep 21, 2026, 4:00 PM ET
$33.95
+$0.40 (+1.18%)
Pre-market: Sep 22, 2026, 5:57 AM ET

Market Data

Market Cap
$1.66B
Enterprise Value
$2.24B
Beta
0.91
Average Volume
550.29K
Shares Outstanding (Diluted)
49.78M
Shares Change YoY
0.62%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US03763A2078

Price Performance

Price Change 1M
-14.4%
Price Change 3M
-18.6%
Price Change 6M
37.0%
Price Change YTD
33.0%
Price Change 1Y
23.9%
Price Change 3Y
12.1%
Price Change 5Y
-64.9%
1M CAGR (ann.)
-6.2%
1Y CAGR (ann.)
12.6%
5Y CAGR (ann.)
-17.8%
All-Time CAGR
7.5%

Valuation

PE Ratio
40.91
Forward PE
16.60
PEG Ratio
0.72
Forward PEG
0.99
PS Ratio
0.43
Forward PS
0.40
PB Ratio
2.00
P/FCF Ratio
10.50
P/Adj. FCF Ratio
15.43
P/OCF Ratio
9.37
EV/Sales
0.58
EV/EBIT
17.59
EV/EBITDA
12.82
EV/FCF
14.15
Earnings Yield
2.4%
FCF Yield
9.5%
Adj. FCF Yield
6.5%

Financial Health

Net Debt
$535.71M
Total Debt
$979.41M
Cash & Short-Term Investments
$400.79M
Total Assets
$2.28B
Current Ratio
1.23
Quick Ratio
1.23
Debt / Equity Ratio
1.18
Debt / EBITDA
5.60
Debt / FCF
6.18
OCF / Debt
0.18
Interest Coverage
1.49
Altman Z-Score
2.76
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
9.2%
Operating Profit Margin
2.6%
EBITDA Margin
4.5%
Net Profit Margin
1.1%
FCF Margin
4.1%
Adj. FCF Margin
2.8%
SBC / Revenue
1.3%
SBC Impact (per share)
-32.0%

Returns

Return on Assets
1.8%
Return on Equity
5.1%
Return on Invested Capital
4.1%
Return on Capital Employed
6.5%
Return on Tangible Assets
3.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
43.7%
Revenue CAGR 5Y
85.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-8.2%
EPS CAGR 5Y
24.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
37.4%
FCF CAGR 5Y
62.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
10
EPS Growth Next 3Y
57.3%
Revenue Growth Next 3Y
10.0%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$0.44
EPS Growth Est (next Q)
4300.0%
Revenue Est (next Q)
$1.02B
Revenue Growth Est (next Q)
6.7%

Fair Value Estimates

Graham Number
$15
Graham Upside
-55.3%
Lynch Fair Value
$19.66
Lynch Upside
-41.4%
Price Target
$52
Price Target Upside
55.0%

Cash Flow

Operating Cash Flow
$175.93M
Free Cash Flow
$158.44M
Adj. Free Cash Flow
$107.78M
FCF Per Share
$3.23
OCF Per Share
$3.58
OCF/S Ratio
4.6%

Income Statement

Revenue
$3.84B
Gross Profit
$354.53M
Operating Income
$100.46M
EBITDA
$174.91M
Net Income
$40.55M
EPS (Diluted)
$0.82
Revenue / Employee
$1.28M
Profit / Employee
$13.52K
Employees
3,000

© 2026 bestshares.com. All rights reserved.